Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vignesh T Packiam

Showing results (101-110 of 136) with videos related to

Pageof 14
Sort By:
The Journal of Urology|July 27, 2022
Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder CancerIan M McElree, Ryan L Steinberg, Alex C Martin, et al.
World Journal of Urology|October 29, 2024
Omission of intraoperative drain placement during robotic partial nephrectomy and robotic radical prostatectomy is safe: an analysis of 18,000 patientsJohn Pfail, Jake Drobner, Alain Kaldany, et al.
Journal of Surgical Education|September 20, 2024
How Do I Match? A Survey Study on the Impact of Step 1 Becoming Pass/FailBenjamin J Lichtbroun, Aravind Rajagopalan, Kevin Chua, et al.
BJU International|August 1, 2024
National Surgical Quality Improvement Program audit of contemporary perioperative care for radical cystectomyJohn Pfail, Jasmin Capellan, Rachel Passarelli, et al.
Urologic Oncology|November 26, 2019
The association of anxiety and depression with perioperative and oncologic outcomes among patients with clear cell renal cell carcinoma undergoing nephrectomyVignesh T Packiam, Mark D Tyson Ii, Matvey Tsivian, et al.
The Journal of Urology|December 21, 2020
Cost-Effectiveness Analysis of Pembrolizumab for Bacillus Calmette-Guérin-Unresponsive Carcinoma In Situ of the BladderKevin M Wymer, Vidit Sharma, Christopher S Saigal, et al.
Urology|July 22, 2015
Contemporary Population-Based Comparison of Localized Ductal Adenocarcinoma and High-Risk Acinar Adenocarcinoma of the ProstateVignesh T Packiam, Sanjay G Patel, Joseph J Pariser, et al.
The Journal of Urology|June 24, 2022
Unplanned Conversion From Partial to Radical Nephrectomy: An Analysis of Incidence, Etiology, and Risk FactorsMatvey Tsivian, Daniel D Joyce, Vignesh T Packiam, et al.
Journal of the National Cancer Institute|November 16, 2019
Prostate Cancer Outcomes Following Solid-Organ Transplantation: A SEER-Medicare AnalysisStanley L Liauw, Sandra A Ham, Lauren C Das, et al.
The Journal of Urology|May 18, 2026
<b>Cost-Effectiveness of Immune Checkpoint Inhibitor Therapy plus BCG for High-Risk Non-muscle Invasive Bladder Cancer: Analyses of CREST</b>, <b>POTOMAC, and ALBAN</b>Daniel D Joyce, Vidit Sharma, Grace E Ratcliff, et al.
Pageof 14

Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
The Journal of Urology|July 27, 2022
Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder CancerIan M McElree, Ryan L Steinberg, Alex C Martin, et al.
World Journal of Urology|October 29, 2024
Omission of intraoperative drain placement during robotic partial nephrectomy and robotic radical prostatectomy is safe: an analysis of 18,000 patientsJohn Pfail, Jake Drobner, Alain Kaldany, et al.
Journal of Surgical Education|September 20, 2024
How Do I Match? A Survey Study on the Impact of Step 1 Becoming Pass/FailBenjamin J Lichtbroun, Aravind Rajagopalan, Kevin Chua, et al.
BJU International|August 1, 2024
National Surgical Quality Improvement Program audit of contemporary perioperative care for radical cystectomyJohn Pfail, Jasmin Capellan, Rachel Passarelli, et al.
Urologic Oncology|November 26, 2019
The association of anxiety and depression with perioperative and oncologic outcomes among patients with clear cell renal cell carcinoma undergoing nephrectomyVignesh T Packiam, Mark D Tyson Ii, Matvey Tsivian, et al.
The Journal of Urology|December 21, 2020
Cost-Effectiveness Analysis of Pembrolizumab for Bacillus Calmette-Guérin-Unresponsive Carcinoma In Situ of the BladderKevin M Wymer, Vidit Sharma, Christopher S Saigal, et al.
Urology|July 22, 2015
Contemporary Population-Based Comparison of Localized Ductal Adenocarcinoma and High-Risk Acinar Adenocarcinoma of the ProstateVignesh T Packiam, Sanjay G Patel, Joseph J Pariser, et al.
The Journal of Urology|June 24, 2022
Unplanned Conversion From Partial to Radical Nephrectomy: An Analysis of Incidence, Etiology, and Risk FactorsMatvey Tsivian, Daniel D Joyce, Vignesh T Packiam, et al.
Journal of the National Cancer Institute|November 16, 2019
Prostate Cancer Outcomes Following Solid-Organ Transplantation: A SEER-Medicare AnalysisStanley L Liauw, Sandra A Ham, Lauren C Das, et al.
The Journal of Urology|May 18, 2026
<b>Cost-Effectiveness of Immune Checkpoint Inhibitor Therapy plus BCG for High-Risk Non-muscle Invasive Bladder Cancer: Analyses of CREST</b>, <b>POTOMAC, and ALBAN</b>Daniel D Joyce, Vidit Sharma, Grace E Ratcliff, et al.
Pageof 14